KI-Beratung Beta

  • Produktbild: Prevention of Progression in Chronic Liver Disease
  • Produktbild: Prevention of Progression in Chronic Liver Disease
Band 138

Prevention of Progression in Chronic Liver Disease An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday

Aus der Reihe Falk Symposium

119,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to...

Beschreibung

In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.


Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.07.2004

Abbildungen

VIII, 130 p.

Herausgeber N. Hiyashi + weitere

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.07.2004

Abbildungen

VIII, 130 p.

Herausgeber
Verlag Springer Netherland
Seitenzahl

130

Maße (L/B/H)

24,1/16/1,3 cm

Gewicht

383 g

Auflage

2004 edition

Sprache

Englisch

ISBN

978-0-7923-8796-1

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Prevention of Progression in Chronic Liver Disease
  • Produktbild: Prevention of Progression in Chronic Liver Disease

  • List of Principal Authors.- Preface. Introduction.- 1: Mechanisms of fibrogenesis.- 2: Non-invasive markers of liver injury.- 3: Complications of cirrhosis: the relevance of hepatocellular carcinoma.- 4: Controlling necroinflammation of liver with SNMC (Stronger Neo Minophagen C): therapy on interferon non-responders.- 5: Predictive parameters of non-response to standard hepatitis treatment.- 6: Concepts for the treatment of non-responders in hepatitis.- 7: Glycyrrhizin: the molecule and present knowledge of action in various liver diseases.- 8: Dendritic cells in immune responses against hepatitis C virus.- 9: SNMC in the prevention of cirrhosis and hepatocellular carcinoma: Japanese experience.- 10: SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials.- Index.